Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead
Completed
- Conditions
- Multi-site Left Ventricular Pacing
- Registration Number
- NCT01044472
- Lead Sponsor
- Abbott Medical Devices
- Brief Summary
The purpose of this clinical investigation is to evaluate the safety and hemodynamic performance of the MSLV Pacing feature in a clinical setting.
- Detailed Description
To evaluate the hemodynamic impact of different pacing MSLV configurations.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 61
Inclusion Criteria
- Patients who have a recognised indication to receive a CRT-D device or an upgrade from a pacemaker or ICD to a CRT-D system.
- Patients have signed an informed consent form indicating their willingness to participate to this study.
Exclusion Criteria
- Patients who are unable to comply with the follow-up schedule based on their geographic location or for any reason.
- Patients with second or third degree AV Block
- Patients with intrinsic atrial rhythm < 40 bpm
- Patients with a previously implanted left ventricular pacing lead.
- Patients who are pregnant.
- Patients currently participating in a clinical investigation that includes an active treatment arm.
- Patients under 18 years of age.
- Patients with a life expectancy of less then 6 months.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (10)
Liverpool Heart and Chest Hospital
🇬🇧Liverpool, United Kingdom
Kerckhoff - Klinik
🇩🇪Bad Nauheim, Germany
Städt. Klinikum
🇩🇪Ludwigshafen, Germany
Herzzentrum
🇩🇪Bad Krozingen, Germany
Schüchtermannklinik
🇩🇪Bad Rothenfelde, Germany
Herz-und Diabetes Zentrum NRW
🇩🇪Bad Oeynhausen, Germany
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
🇩🇪Frankfurt, Germany
Klinikum Rosenheim
🇩🇪Rosenheim, Germany
Russells Hall
🇬🇧Dudley, United Kingdom
St Thomas
🇬🇧London, United Kingdom